Evidence map›Paper›PMID 36572835›Full record

ArticleAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2023

Selective profiling of liver-related specific proteins based on sofosbuvir-modified magnetic separation material.

Yini Pan, Zhenxin Wang, Sen Xu, Lingyi Zhang, Weibing Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yini PanShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, People's Republic of China.
Zhenxin WangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Sen XuShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, People's Republic of China.
Lingyi ZhangShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, People's Republic of China. zhanglingyi@ecust.edu.cn.ORCID http://orcid.org/0000-0003-1690-578X
Weibing ZhangShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, People's Republic of China. weibingzhang@ecust.edu.cn.
East China University of Science and Technology · CNSun Yat-sen University · CN

Funding

National Natural Science Foundation of China 21974045National Natural Science Foundation of China 82102503the Fundamental Research Funds for the Central Universities JKJ01221718the National Key R&D Program of China 2021YFF0701900the Science and Technology Commission of Shanghai Municipality 19142201100the Science and Technology Commission of Shanghai Municipality 6142200500Zhongshan Hospital Fudan University Youth Foundation 2020ZSQN30
6 · The paper itself

Abstract

It has great significance in profiling specific proteins throughout for better understanding of complex pathological processes and in-depth pharmacological studies. In this work, an efficient protein profiling strategy was developed based on the specific protein-drug interaction. Sofosbuvir (SOF), as a first-line drug for the treatment of hepatitis C, was modified onto the surface of nanoparticles through stable chemical bonds to fabricate a novel magnetic separation material denoted as Fe

Indexed as

Carcinoma, HepatocellularHepatitis C, ChronicLiver NeoplasmsAntiviral AgentsGenotypeHumansMagnetic PhenomenaSilicon DioxideSofosbuvirAntiviral AgentsSilicon DioxideSofosbuvirLiver diseasesProtein profilingProteomicsSeparation materialSofosbuvir

Identifiers

PMID36572835
OpenAlexW4312185958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.